JWH-161
http://dbpedia.org/resource/JWH-161 an entity of type: Thing
JWH-161 is a cannabinoid derivative that was designed by Dr John W. Huffman's team as a hybrid between the dibenzopyran "classical" cannabinoid drugs and the novel indole derivatives, in an attempt to unravel the differences in their binding modes to the CB1 receptor. While retaining structural elements from both families, JWH-161 has a CB1 Ki of 19.0nM, although it was found to be slightly weaker than THC in animal tests.
rdf:langString
rdf:langString
JWH-161
xsd:integer
28832071
xsd:integer
1058915075
xsd:integer
27
xsd:integer
8606713
xsd:integer
33
xsd:integer
-255
xsd:integer
1
xsd:integer
2
xsd:integer
10431286
rdf:langString
Oc3c5c1ccccc1nCCCCC
xsd:integer
1
rdf:langString
VDJUAFPNHZRTNL-WOJBJXKFSA-N
xsd:integer
413559074
xsd:integer
240
rdf:langString
JWH-161 is a cannabinoid derivative that was designed by Dr John W. Huffman's team as a hybrid between the dibenzopyran "classical" cannabinoid drugs and the novel indole derivatives, in an attempt to unravel the differences in their binding modes to the CB1 receptor. While retaining structural elements from both families, JWH-161 has a CB1 Ki of 19.0nM, although it was found to be slightly weaker than THC in animal tests.
xsd:nonNegativeInteger
2053
xsd:string
10431286